127 related articles for article (PubMed ID: 25060817)
1. Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation.
Zhou DY; Ding N; Du ZY; Cui XX; Wang H; Wei XC; Conney AH; Zhang K; Zheng X
Mol Med Rep; 2014 Sep; 10(3):1315-22. PubMed ID: 25060817
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of the expression of prostate specific antigen by curcumin].
Yang L; Zhang LY; Chen WW; Kong F; Zhang PJ; Hu XY; Zhang JY; Cui FA
Yao Xue Xue Bao; 2005 Sep; 40(9):800-3. PubMed ID: 16342680
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
4. Effects of curcumin analogues for inhibiting human prostate cancer cells and the growth of human PC-3 prostate xenografts in immunodeficient mice.
Zhou DY; Ding N; Van Doren J; Wei XC; Du ZY; Conney AH; Zhang K; Zheng X
Biol Pharm Bull; 2014; 37(6):1029-34. PubMed ID: 24647337
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of curcumin-related compounds for anticancer activity.
Wei X; Du ZY; Zheng X; Cui XX; Conney AH; Zhang K
Eur J Med Chem; 2012 Jul; 53():235-45. PubMed ID: 22551677
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activation of the androgen receptor by bombesin and low-dose androgen.
Dai J; Shen R; Sumitomo M; Stahl R; Navarro D; Gershengorn MC; Nanus DM
Clin Cancer Res; 2002 Jul; 8(7):2399-405. PubMed ID: 12114445
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.
Alexander B; Fishman AI; Green D; Choudhury MS; Konno S
Urol Oncol; 2013 Jan; 31(1):104-9. PubMed ID: 21795077
[TBL] [Abstract][Full Text] [Related]
9. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.
Tsui KH; Feng TH; Lin CM; Chang PL; Juang HH
J Androl; 2008; 29(6):661-8. PubMed ID: 18676361
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
van der Poel HG
Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
[TBL] [Abstract][Full Text] [Related]
11. Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer.
Ide H; Lu Y; Noguchi T; Muto S; Okada H; Kawato S; Horie S
Cancer Sci; 2018 Apr; 109(4):1230-1238. PubMed ID: 29369461
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin.
Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G
Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804
[TBL] [Abstract][Full Text] [Related]
13. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines.
Nakamura K; Yasunaga Y; Segawa T; Ko D; Moul JW; Srivastava S; Rhim JS
Int J Oncol; 2002 Oct; 21(4):825-30. PubMed ID: 12239622
[TBL] [Abstract][Full Text] [Related]
14. Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor.
Guo H; Xu YM; Ye ZQ; Yu JH; Hu XY
Pharmazie; 2013 Jun; 68(6):431-4. PubMed ID: 23875250
[TBL] [Abstract][Full Text] [Related]
15. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
[TBL] [Abstract][Full Text] [Related]
16. Effect of curcumin on the interaction between androgen receptor and Wnt/β-catenin in LNCaP xenografts.
Hong JH; Lee G; Choi HY
Korean J Urol; 2015 Sep; 56(9):656-65. PubMed ID: 26366279
[TBL] [Abstract][Full Text] [Related]
17. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
18. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA
Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911
[TBL] [Abstract][Full Text] [Related]
20. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
